Weiyi Peng
University of Houston · 329 works · 10,025 citations · h-index 38
Top works
- BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
- Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
- Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell Function
- PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines
- BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer
- Tumor-Infiltrating γδ T Cells Suppress T and Dendritic Cell Function via Mechanisms Controlled by a Unique Toll-like Receptor Signaling Pathway
- Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
- CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
- Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses
- Development of Immunotherapy Combination Strategies in Cancer
- Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
- 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
- Enhanced Differentiation of Splenic Plasma Cells but Diminished Long-Lived High-Affinity Bone Marrow Plasma Cells in Aged Mice
- Tumor-Associated Galectin-3 Modulates the Function of Tumor-Reactive T Cells
- Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications
- The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy
- HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes
- The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression